OBJECTIVE: To retrospectively compare the efficacy of suprascapular nerve block (SSNB) versus interscalene block (ISB) for analgesia after arthroscopic rotator cuff repair (ARCR). METHODS: Ninety-seven patients who underwent ARCR were retrospectively divided into three groups. Group S comprised 33 patients who received SSNB, group I comprised 52 patients who received ISB, and group C comprised 12 patients who received a glenohumeral injection as a control. SSNB and ISB were performed with 20 ml of 0.375% ropivacaine before surgery, while glenohumeral injection was performed after surgery. The Visual analog scale (VAS) pain scores were recorded at 1,3, and 6 h and 1, 3, and 6 days postoperatively. The total number of additional analgesic administrations was also counted for 6 days postoperatively. RESULTS: Compared with group C, the VAS pain score was significantly lower in group S at 1 h and 6 days postoperatively, and in group I at 1 and 3 h postoperatively. There were no significant differences between groups S and I in the VAS pain scores, or the administration of additional analgesia. There were no major complications associated with SSNB or ISB. CONCLUSION: There were no significant differences between SSNB and ISB in the duration of analgesia and the VAS pain scores after ARCR.
OBJECTIVE: To retrospectively compare the efficacy of suprascapular nerve block (SSNB) versus interscalene block (ISB) for analgesia after arthroscopic rotator cuff repair (ARCR). METHODS: Ninety-seven patients who underwent ARCR were retrospectively divided into three groups. Group S comprised 33 patients who received SSNB, group I comprised 52 patients who received ISB, and group C comprised 12 patients who received a glenohumeral injection as a control. SSNB and ISB were performed with 20 ml of 0.375% ropivacaine before surgery, while glenohumeral injection was performed after surgery. The Visual analog scale (VAS) pain scores were recorded at 1,3, and 6 h and 1, 3, and 6 days postoperatively. The total number of additional analgesic administrations was also counted for 6 days postoperatively. RESULTS: Compared with group C, the VAS pain score was significantly lower in group S at 1 h and 6 days postoperatively, and in group I at 1 and 3 h postoperatively. There were no significant differences between groups S and I in the VAS pain scores, or the administration of additional analgesia. There were no major complications associated with SSNB or ISB. CONCLUSION: There were no significant differences between SSNB and ISB in the duration of analgesia and the VAS pain scores after ARCR.
Authors: Deborah Faryniarz; Christine Morelli; Struan Coleman; Tara Holmes; Answorth Allen; David Altchek; Frank Cordasco; Russell F Warren; Michael K Urban; Michael A Gordon Journal: J Shoulder Elbow Surg Date: 2006-09-01 Impact factor: 3.019
Authors: Anshu Singh; Charles Kelly; Travis O'Brien; Jeffrey Wilson; Jon J P Warner Journal: J Bone Joint Surg Am Date: 2012-11-21 Impact factor: 5.284
Authors: Jae Jun Lee; Do-Young Kim; Jung-Taek Hwang; Sang-Soo Lee; Sung Mi Hwang; Gi Ho Kim; Yoon-Geol Jo Journal: Arthroscopy Date: 2014-05-29 Impact factor: 4.772
Authors: Nasir Hussain; Ghazaleh Goldar; Neli Ragina; Laura Banfield; John G Laffey; Faraj W Abdallah Journal: Anesthesiology Date: 2017-12 Impact factor: 7.892